Immediate Impact

2 by Nobel laureates 93 standout
Sub-graph 1 of 23

Citing Papers

Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models
2023 Standout
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
2022 Standout
2 intermediate papers

Works of Christopher S. Carlin being referenced

A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis
2004

Author Peers

Author Last Decade Papers Cites
Christopher S. Carlin 138 217 9 50 8 281
Kamyar Farahi 144 199 2 49 7 286
A. Galluccio 154 186 1 62 10 262
Stephanie Mehlis 143 241 2 46 14 291
Mona Malakouti 148 218 6 32 15 306
M. Viguier 139 174 1 36 12 233
I. Flytström 105 169 29 38 7 230
L. Manounah 139 169 2 35 9 290
C. Karimkhani Aksut 122 159 3 33 4 242
Jai-Il Youn 132 233 4 34 12 309
Manan D. Mehta 113 201 4 44 7 294

All Works

Loading papers...

Rankless by CCL
2026